{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:22:45Z","timestamp":1791404565348,"version":"4.3.3"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T00:00:00Z","timestamp":1570406400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010969","name":"Alzheimer Nederland","doi-asserted-by":"publisher","award":["15007"],"award-info":[{"award-number":["15007"]}],"id":[{"id":"10.13039\/501100010969","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.neurobiolaging.2019.09.020","type":"journal-article","created":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T19:48:15Z","timestamp":1571168895000},"page":"96-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"special_numbering":"C","title":["Linking APOE-\u03b54, blood-brain barrier dysfunction, and inflammation to Alzheimer's pathology"],"prefix":"10.1016","volume":"85","author":[{"given":"Joost M.","family":"Riphagen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inez H.G.M.","family":"Ramakers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Whitney M.","family":"Freeze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda H.G.","family":"Pagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard J.","family":"Hanseeuw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel M.","family":"Verbeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans R.J.","family":"Verhey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi I.L.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Albert","year":"2011","journal-title":"J.\u00a0Alzheimer's Assoc."},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib2","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nature11087","article-title":"Apolipoprotein E controls cerebrovascular integrity via cyclophilin A","volume":"485","author":"Bell","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib3","doi-asserted-by":"crossref","first-page":"E1289","DOI":"10.1073\/pnas.1710329115","article-title":"Tau induces blood vessel abnormalities and angiogenesis-related gene expression in P301L transgenic mice and human Alzheimer's disease","volume":"115","author":"Bennett","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000116919","article-title":"Protein analysis in cerebrospinal fluid","volume":"33","author":"Blennow","year":"1993","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.brainres.2009.12.039","article-title":"Apolipoprotein E protects cultured pericytes and astrocytes from D-Abeta(1-40)-mediated cell death","volume":"1315","author":"Bruinsma","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib6","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3233\/JAD-2011-101959","article-title":"Blood-cerebrospinal fluid barrier permeability in Alzheimer\u2019s disease","volume":"25","author":"Chalbot","year":"2011","journal-title":"J.\u00a0Alzheimer's Dis."},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib7","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.bbi.2016.09.027","article-title":"Does neuroinflammation drive the relationship between tau hyperphosphorylation and dementia development following traumatic brain injury?","volume":"60","author":"Collins-Praino","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib8","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1471-2172-10-52","article-title":"Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays","volume":"10","author":"de Jager","year":"2009","journal-title":"BMC Immunol."},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib9","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0149-7634(94)90052-3","article-title":"Impaired brain microcirculation may trigger Alzheimer's disease","volume":"18","author":"de la Torre","year":"1994","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib10","first-page":"1691","article-title":"Randomized trial of Verubecestat for mild-to-moderate","volume":"378","author":"Egan","year":"2018","journal-title":"Alzheimer\u2019s Dis."},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib11","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1001\/archneur.64.3.noc60123","article-title":"Cerebrospinal fluid tau\/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults","volume":"64","author":"Fagan","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib12","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.3174\/ajnr.A5273","article-title":"Pericortical Enhancement on delayed Postgadolinium fluid-Attenuated Inversion Recovery Images in normal aging, mild cognitive impairment, and Alzheimer disease","volume":"38","author":"Freeze","year":"2017","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib13","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1176\/ajp.156.4.531","article-title":"Association between memory complaints and incident Alzheimer's disease in elderly people with normal baseline cognition","volume":"156","author":"Geerlings","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib14","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1158\/0008-5472.CAN-15-1227","article-title":"Interleukin-6 Stimulates defective angiogenesis","volume":"75","author":"Gopinathan","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib15","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1073\/pnas.83.13.4913","article-title":"Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology","volume":"83","author":"Grundke-Iqbal","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2019.09.020_bib68","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.3233\/JAD-160524","article-title":"A common variant of IL-6R is associated with elevated IL-6 pathway activity in Alzheimer\u2019s disease brains","volume":"56","author":"Haddick","year":"2017","journal-title":"Journal of Alzheimer\u2019s disease\u202f: JAD"},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib16","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.bbrc.2003.12.096","article-title":"IL-6 plays a critical role in the synergistic induction of human serum amyloid A (SAA) gene when stimulated with proinflammatory cytokines as analyzed with an SAA isoform real-time quantitative RT-PCR assay system","volume":"314","author":"Hagihara","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib17","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/jcbfm.2015.44","article-title":"Accelerated pericyte degeneration and blood\u2013brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer\u2019s disease","volume":"36","author":"Halliday","year":"2016","journal-title":"J.\u00a0Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib18","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.exger.2009.10.010","article-title":"Total and Phosphorylated tau protein as biological markers of Alzheimer's disease","volume":"45","author":"Hampel","year":"2010","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib19","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/ni.2001","article-title":"The immune system in atherosclerosis","volume":"12","author":"Hansson","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib20","first-page":"1","article-title":"Inflammatory biomarkers interleukin-6 and C-reactive protein and outcomes in stable coronary heart disease: experiences from the STABILITY (Stabilization of Atherosclerotic plaque by Initiation of Darapladib Therapy) trial","volume":"6","author":"Held","year":"2017","journal-title":"J.\u00a0Am. Heart Assoc."},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib21","first-page":"321","article-title":"Trial of Solanezumab for mild dementia","volume":"378","author":"Honig","year":"2018","journal-title":"Due Alzheimer\u2019s Dis."},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib22","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1001\/jamaneurol.2014.186","article-title":"Arterial stiffness and beta-amyloid progression in nondemented elderly adults","volume":"71","author":"Hughes","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib23","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.neuron.2014.12.056","article-title":"Dangerous Leaks: blood-brain barrier Woes in the aging Hippocampus","volume":"85","author":"Iadecola","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib24","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.neuron.2013.10.008","article-title":"The pathobiology of vascular dementia","volume":"80","author":"Iadecola","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib25","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.neurobiolaging.2016.11.017","article-title":"Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype","volume":"51","author":"Janelidze","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib26","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1001\/jama.2015.4668","article-title":"Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis","volume":"313","author":"Jansen","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib27","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1001\/archgenpsychiatry.2010.30","article-title":"Prediction of dementia by subjective memory impairment: effects of severity and temporal association with cognitive impairment","volume":"67","author":"Jessen","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib28","series-title":"semTools: Useful tools for structural equation modeling. R package version 0.5-1","author":"Jorgensen","year":"2018"},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib29","doi-asserted-by":"crossref","first-page":"8843","DOI":"10.1523\/JNEUROSCI.2868-05.2005","article-title":"Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease","volume":"25","author":"Kitazawa","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib30","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/ana.21696","article-title":"Apolipoprotein E-dependent accumulation of Alzheimer disease-related lesions begins in middle age","volume":"65","author":"Kok","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib31","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/gerona\/gls187","article-title":"The role of peripheral inflammatory markers in dementia and Alzheimer's disease: a meta-analysis","volume":"68","author":"Koyama","year":"2013","journal-title":"J.\u00a0Gerontol. A. Biol. Sci. Med. Sci."},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib32","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","article-title":"The TREM2-APOE pathway drives the Transcriptional Phenotype of dysfunctional microglia in neurodegenerative diseases","volume":"47","author":"Krasemann","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib33","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1212\/WNL.0b013e3181e8e8b8","article-title":"Comparing predictors of conversion and decline in mild cognitive impairment","volume":"75","author":"Landau","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib34","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13024-017-0192-x","article-title":"Glial contributions to neurodegeneration in tauopathies","volume":"12","author":"Leyns","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib35","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1037\/1082-989X.4.1.84","article-title":"Sample size in factor analysis","volume":"4","author":"MacCallum","year":"1999","journal-title":"Psychol. Methods"},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib36","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.2353\/ajpath.2009.090059","article-title":"Interferon-{gamma} differentially affects Alzheimer's disease pathologies and induces neurogenesis in triple transgenic-AD mice","volume":"175","author":"Mastrangelo","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib37","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"J.\u00a0Alzheimer's Assoc."},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib38","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.bbalip.2006.03.013","article-title":"Serum amyloid A (SAA)-induced remodeling of CSF-HDL","volume":"1761","author":"Miida","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib39","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1084\/jem.20171406","article-title":"Alzheimer\u2019s disease: a matter of blood\u2013brain barrier dysfunction?","volume":"214","author":"Montagne","year":"2017","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib40","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1207\/S15328007SEM0904_8","article-title":"How to use a Monte Carlo study to decide on sample size and determine power","volume":"9","author":"Muth\u00e9n","year":"2002","journal-title":"Struct. Equation Model."},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib41","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41591-018-0297-y","article-title":"Blood\u2013brain barrier breakdown is an early biomarker of human cognitive dysfunction","volume":"25","author":"Nation","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib42","doi-asserted-by":"crossref","first-page":"17536","DOI":"10.1074\/jbc.M111.225532","article-title":"Apolipoprotein E regulates the integrity of tight junctions in an isoform-dependent manner in an in\u00a0vitro blood-brain barrier model","volume":"286","author":"Nishitsuji","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib43","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/nm.3407","article-title":"Development, maintenance and disruption of the blood-brain barrier","volume":"19","author":"Obermeier","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib44","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.4049\/jimmunol.161.9.4992","article-title":"Role of IL-6 and the soluble IL-6 receptor in inhibition of VCAM-1 gene expression","volume":"161","author":"Oh","year":"1998","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib45","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.yexcr.2004.01.002","article-title":"Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5\/p35 pathway","volume":"295","author":"Quintanilla","year":"2004","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib46","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.dadm.2015.11.006","article-title":"Cerebrospinal fluid ratios with Abeta42 predict preclinical brain beta-amyloid accumulation","volume":"2","author":"Racine","year":"2016","journal-title":"Alzheimers Dement. (Amst)"},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib47","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1161\/CIRCULATIONAHA.113.007469","article-title":"Increased pericyte coverage mediated by endothelial-derived fibroblast growth factor-2 and interleukin-6 is a source of smooth muscle-like cells in pulmonary hypertension","volume":"129","author":"Ricard","year":"2014","journal-title":"Circulation"},{"issue":"6 Pt A","key":"10.1016\/j.neurobiolaging.2019.09.020_bib48","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.bbamcr.2016.03.018","article-title":"The role of interleukin-6 signaling in nervous tissue","volume":"1863","author":"Rothaug","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib49","first-page":"322","article-title":"Two phase 3 trials of Bapineuzumab in","volume":"370","author":"Salloway","year":"2014","journal-title":"Mild-to-Moderate Alzheimer's Dis."},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib50","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jalz.2014.06.012","article-title":"Subjective cognitive concerns, episodic memory, and the APOE \u03b54 allele. Alzheimer's & Dementia","volume":"10","author":"Samieri","year":"2014","journal-title":"J.\u00a0Alzheimer's Assoc."},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib51","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/s41577-018-0008-4","article-title":"Clocking in to immunity","volume":"18","author":"Scheiermann","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib52","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1161\/01.HYP.36.5.801","article-title":"Systolic and diastolic blood pressure, pulse pressure, and mean arterial pressure as predictors of cardiovascular disease risk in Men","volume":"36","author":"Sesso","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib53","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/s41577-018-0051-1","article-title":"Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight","volume":"18","author":"Shi","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib54","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature24016","article-title":"ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy","volume":"549","author":"Shi","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib55","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/jama.2018.21442","article-title":"Effect of intensive vs standard blood pressure control on probable dementia: a randomized clinical trial effect of intensive vs standard blood pressure control on probable dementia effect of intensive vs standard blood pressure control on probable dementia","volume":"321","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib56","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.biopsych.2010.06.012","article-title":"A\u00a0meta-analysis of cytokines in Alzheimer's disease","volume":"68","author":"Swardfager","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib57","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/ana.24921","article-title":"Low normal cerebrospinal fluid Abeta42 levels predict clinical progression in nondemented subjects","volume":"81","author":"Tijms","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib58","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1146\/annurev.iy.13.040195.001343","article-title":"Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity","volume":"13","author":"Trinchieri","year":"1995","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib59","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0304-3940(95)11763-M","article-title":"ApoE immunoreactivity and microglial cells in Alzheimer's disease brain","volume":"195","author":"Uchihara","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib60","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1097\/NEN.0b013e3181836a71","article-title":"Cerebral small vessel disease-induced apolipoprotein E leakage is associated with Alzheimer disease and the accumulation of amyloid beta-protein in perivascular astrocytes","volume":"67","author":"Utter","year":"2008","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib61","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12974-019-1454-z","article-title":"Balance between innate versus adaptive immune system and the risk of dementia: a population-based cohort study","volume":"16","author":"van der Willik","year":"2019","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib62","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1212\/WNL.59.3.371","article-title":"Interleukin-6 and risk of cognitive decline","volume":"59","author":"Weaver","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib63","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00401-009-0627-8","article-title":"Choroid plexus: biology and pathology","volume":"119","author":"Wolburg","year":"2010","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib64","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1177\/0013164413495237","article-title":"Sample size Requirements for structural equation models: an Evaluation of power, bias, and Solution Propriety","volume":"76","author":"Wolf","year":"2013","journal-title":"Educ. Psychol. Meas."},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib65","doi-asserted-by":"crossref","first-page":"a006346","DOI":"10.1101\/cshperspect.a006346","article-title":"Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature","volume":"2","author":"Wyss-Coray","year":"2012","journal-title":"Cold Spring Harbor Perspect. Med."},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib66","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","article-title":"Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model","volume":"53","author":"Yoshiyama","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2019.09.020_bib67","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrn3114","article-title":"Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders","volume":"12","author":"Zlokovic","year":"2011","journal-title":"Nat. Rev. Neurosci."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458019303550?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458019303550?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T05:49:16Z","timestamp":1777528156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458019303550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":68,"alternative-id":["S0197458019303550"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2019.09.020","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Linking APOE-\u03b54, blood-brain barrier dysfunction, and inflammation to Alzheimer's pathology","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2019.09.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}